Ten years ago, Orrbitt started with a simple belief: biotech deserves better creative. Not safer. Not diluted. Not recycled thinking dressed up as strategy. Better. Since then, we've been in the room when it counts, pulling companies out of stealth, shaping brands under pressure, and turning complex science into investor-ready clarity at the moments that define company value. We don't chase trends or play it safe. The stakes are too high. What defines us is the standard. Push harder. Think sharper. Cut nothing that matters. Ten years in, we're more opinionated, more precise, and far from finished.